Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32572920)

  • 1. Silence of ATAD2 inhibits proliferation of colorectal carcinoma via the Rb-E2F1 signaling.
    Wang JH; Yu TT; Li Y; Hao YP; Han L; Xu KY; Xu P
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6055-6063. PubMed ID: 32572920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer.
    Zhou X; Ji H; Ye D; Li H; Liu F; Li H; Xu J; Li Y; Xiang F
    Cancer Manag Res; 2020; 12():337-351. PubMed ID: 32021447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
    Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
    Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
    Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
    Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
    Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
    Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
    Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
    He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
    Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
    Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
    Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
    Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C
    Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
    Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
    Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
    Ekin U; Yuzugullu H; Ozen C; Korhan P; Bagirsakci E; Yilmaz F; Yuzugullu OG; Uzuner H; Alotaibi H; Kirmizibayrak PB; Atabey N; Karakülah G; Ozturk M
    J Gastrointest Cancer; 2021 Dec; 52(4):1356-1369. PubMed ID: 34738187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.
    Tong Y; Li J; Peng M; Qian Q; Shi W; Chen Z; Liu B
    Biochem Biophys Res Commun; 2022 Feb; 594():146-152. PubMed ID: 35085891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
    Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
    Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
    J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2.
    Wu S; Han M; Zhang C
    J Cell Physiol; 2019 Aug; 234(10):19059-19072. PubMed ID: 30993715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.
    Liu Q; Liu H; Li L; Dong X; Ru X; Fan X; Wen T; Liu J
    Int J Oncol; 2020 Jan; 56(1):219-231. PubMed ID: 31746426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
    Sun T; Du B; Diao Y; Li X; Chen S; Li Y
    BMB Rep; 2019 Jul; 52(7):457-462. PubMed ID: 31186081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.